Active therapy and models of care for adolescents and young adults with cancer

Cancer

Volumn 117, Issue SUPPL. 10, 2011, Pages 2316-2322

  Ramphal, Raveena ^a   Meyer, Ralph ^b   Schacter, Brent ^c   Rogers, Paul ^d   Pinkerton, Ross ^e  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c CancerCare Manitoba ^*  (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

adolescents; health care delivery; hospital; neoplasms; oncology service; young adults

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; COMMUNICATION SKILL; EDUCATION PROGRAM; HEALTH CARE DELIVERY; HEALTH CARE NEED; HUMAN; OVERALL SURVIVAL; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT REFERRAL; PATIENT SATISFACTION; PEER COUNSELING; PERSONAL AUTONOMY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SUPPORT GROUP; AWARENESS; CONFERENCE PAPER; INTERHOSPITAL COOPERATION; MALIGNANT NEOPLASTIC DISEASE; MEDICAL CARE; MEDICAL EDUCATION; PATIENT ATTITUDE; PATIENT CARE; POLITICAL PARTICIPATION;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; DELIVERY OF HEALTH CARE; HEALTH PLANNING GUIDELINES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; YOUNG ADULT;

EID: 79955515066     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26048     Document Type: Article

References (30)

1. Bleyer A, Albritton KH, Ries LAG, Barr RD,. Introduction. In:, Bleyer A, Barr RD, eds. Cancer in Adolescents and Young Adults. Berlin: Springer-Verlag; 2007: 7-15.
2. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Special Topic: Cancer in Adolescents and Young Adults. Toronto, Ontario, Canada: Canadian Cancer Society; 2009: 82-83.
3. Pollock BH, Krischer JP, Vietti TJ,. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991; 119: 725-732.
4. Collins SR, Schoen C, Kriss JL, Doty MM, Mahato B,. Rite of passage? Why young adults become uninsured and how new policies can help. Issue Brief (Commonw Fund). 2006; 20: 1-14.
5. Ziv A, Boulet JR, Slap GB,. Utilization of physician offices by adolescents in the United States. Pediatrics. 1999; 104 (1 pt 1): 35-42. (Pubitemid 29315844)
6. Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V,. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg. 2004; 28: 716-720. (Pubitemid 39097132)
7. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ,. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353: 1119-1126. (Pubitemid 29155203)
8. Albritton KH, Wiggins CH, Nelson HE, Weeks JC,. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007; 25: 4616-4621. (Pubitemid 350035321)
9. Klein-Geltink J, Shaw AK, Morrison HI, Barr RD, Greenberg ML,. Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer. 2005; 41: 404-410. (Pubitemid 40187212)
10. Roush SW, Krischer JP, Cox MW, Pollock BH,. Socioeconomic and demographic factors that predict where children receive cancer care in Florida. J Clin Epidemiol. 1993; 46: 535-544. (Pubitemid 23194278)
11. Brady AM, Harvey C,. The practice patterns of adult oncologists' care of pediatric oncology patients. Cancer. 1993; 71 (10 suppl): 3237-3240. (Pubitemid 23148503)
12. Bleyer A, Budd T, Montello M,. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006; 107 (7 suppl): 1645-1655. (Pubitemid 44537071)
13. Peppercorn JM, Weeks JC, Cook EF, Joffe S,. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004; 363: 263-270. (Pubitemid 38142408)
14. van Hoff J, Schymura MJ, Curnen MG,. Trends in the incidence of childhood and adolescent cancer in Connecticut, 1935-1979. Med Pediatr Oncol. 1988; 16: 78-87.
15. Albritton KH, Bleyer A,. The management of cancer in the older adolescent. Eur J Cancer. 2003; 39: 2584-2599.
16. Greenberg ML, Barr RD, DiMonte B, McLaughlin E, Greenberg C,. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003; 105: 88-91. (Pubitemid 36418490)
17. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997; 21: 366-373. (Pubitemid 27514842)
18. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008; 112: 1646-1654.
19. Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol. 2007; 25: 813-819. (Pubitemid 350002881)
20. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003; 21: 774-780. (Pubitemid 46606434)
21. Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000; 18: 547-561. (Pubitemid 30078536)
22. Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010; 116: 3189-3194.
23. Sinkovics JG, Plager C, Ayala AG, Lindberg RD, Samuels ML,. Ewing sarcoma: its course and treatment in 50 adult patients. Oncology. 1980; 37: 114-119. (Pubitemid 10169119)
24. Siegel RD, Ryan LM, Antman KH,. Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol. 1988; 11: 614-617.
25. Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C,. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997; 8: 1099-1105. (Pubitemid 27521217)
26. Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol. 2000; 39: 111-116.
27. Pieper S, Ranft A, Braun-Munzinger G, Jurgens H, Paulussen M, Dirksen U,. Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99. Onkologie. 2008; 31: 657-663.
28. Bleyer A,. The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer. 2010; 54: 238-241.
29. Niewerth D, Creutzig U, Bierings MB, Kaspers GJ,. A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia. Blood. 2010; 116: 2205-2214.
30. Nachman JB, La MK, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol. 2009; 27: 5189-5194.